Obesity and Diabetes
New obesity and diabetes study findings reported from A.M. Wolf and co-authors
Published in Obesity and Diabetes Week, September 3rd, 2007
According to recent research published in the journal Obesity Surgery, "Changes in metabolic risk factors such as dyslipidemia and hyperinsulinemia as well as levels of sex hormones and leptin were studied in morbidly obese (MO) and super-obese (SO) patients during excess weight loss (EWL), separately in males and females. In this prospective clinical intervention study, 431 patients were included (361 females and 70 males)."
"There were 217 patients with MO (BMI 40-49.9 kg/m(2)) and 214 patients with SO (BMI >= 50 kg/m(2)). All patients underwent restrictive bariatric operations. Metabolic parameters (lipids, insulin, leptin, hepatic transaminases, uric acid,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Biomedicine
Weight Loss Surgery Extends Lifespan - Obesity
Hypertension appears to be frequently undiagnosed in children and adolescents - Obesity and Diabetes
Clinical Trial Tests Surgery as Teen Obesity Treatment - Obesity and Diabetes
Despite Overeating, Morbidly Obese Mice Gain Protection Against Diabetes - Obesity and Diabetes
Gastric Bypass Reduces Mortality Risk in Severely Obese - Obesity and Diabetes
Your Gut Has Taste Receptors: Researchers Identify Link to Obesity and Diabetes - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
